skip to primary navigationskip to content
 

GeneAdviser raises £350K to boost uptake of genomic medicine

last modified Jun 02, 2016 08:50 AM
GeneAdviser, an online ordering platform for clinical genetic testing, has raised £350,000 in its first round of seed funding, backed by Cambridge biotech angel Dr Jonathan Milner.
Formed by a growing team of Cambridge scientists and geneticists, the company provides an independent platform for clinicians to quickly compare and order specialist genetics services, advancing the uptake of genomic medicine into the healthcare market.
The £350,000 seed round is led by Abcam founder and life science investor Jonathan Milner, who joins the board of directors as company chairman. Further funds are contributed by Dr Darrin Disley (Horizon Discovery), Dr Chris Torrance (Phoremost), Simon Thorpe (Delta2020), Martlet and other individual investors.
GeneAdviser fills a great need for accessible genetic testing and will significantly impact the lives of patients with rare disease, cancer and neurological conditions,” says Dr Milner. “It shows real potential to scale quickly and become the market leader in this space. I’m impressed by the way the team has created the platform over the past year and look forward to helping them make their ambitious longer-term plans a reality.”
Clinicians are already using GeneAdviser to order specialist genetic tests from the NHS Regional Genetics Centre at Addenbrooke’s Hospital in Cambridge. This funding will allow GeneAdviser to expand the ordering platform into a broader marketplace, making it easier for clinicians worldwide to select and order genetics services. 
Link to the full story: http://bit.ly/GeneAdviser-funding

RSS Feed Latest news

Sparrho Spreads its Wings

Jul 17, 2017

Sparrho raises $3 million to democratize access to science research

Silver Medal Awarded to Breath Biopsy Pioneer Billy Boyle

Jul 04, 2017

Owlstone Medical CEO Billy Boyle wins Royal Academy of Engineering’s Silver Medal

ideaSpace Alumni close three funding deals in a week

Jun 26, 2017

£4.3m raised in an exceptional 7 days for SyndicateRoom

Life sciences equity crowdfunding platform, Capital Cell shortlisted for international award

Jun 23, 2017

Shortlisted for the Best International Growth Business award at the UK Business Angels Association Investment Awards 2017

Addenbrooke's takes over the GeneAdviser ordering platform for genetic testing

Jun 21, 2017

GeneAdviser's platform to live on as in-house NHS tool

View all news